Pacific Shuanglin Bio-pharmacy Co., LTD

SZSE:000403 Stok Raporu

Piyasa değeri: CN¥16.6b

Pacific Shuanglin Bio-pharmacy Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Pacific Shuanglin Bio-pharmacy has been growing earnings at an average annual rate of 33.6%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 23.1% per year. Pacific Shuanglin Bio-pharmacy's return on equity is 10.6%, and it has net margins of 29.1%.

Anahtar bilgiler

33.6%

Kazanç büyüme oranı

26.2%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.3%
Gelir büyüme oranı23.1%
Özkaynak getirisi10.6%
Net Marj29.1%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

If EPS Growth Is Important To You, Pacific Shuanglin Bio-pharmacy (SZSE:000403) Presents An Opportunity

Oct 10
If EPS Growth Is Important To You, Pacific Shuanglin Bio-pharmacy (SZSE:000403) Presents An Opportunity

Pacific Shuanglin Bio-pharmacy Co., LTD's (SZSE:000403) Shares May Have Run Too Fast Too Soon

Aug 16
Pacific Shuanglin Bio-pharmacy Co., LTD's (SZSE:000403) Shares May Have Run Too Fast Too Soon

We Think Pacific Shuanglin Bio-pharmacy (SZSE:000403) Can Stay On Top Of Its Debt

Jul 22
We Think Pacific Shuanglin Bio-pharmacy (SZSE:000403) Can Stay On Top Of Its Debt

Is Now The Time To Put Pacific Shuanglin Bio-pharmacy (SZSE:000403) On Your Watchlist?

May 24
Is Now The Time To Put Pacific Shuanglin Bio-pharmacy (SZSE:000403) On Your Watchlist?

Gelir ve Gider Dağılımı

Pacific Shuanglin Bio-pharmacy nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:000403 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 242,84482946572
30 Jun 242,75679645784
31 Mar 242,50467846886
31 Dec 232,32961246480
30 Sep 232,28756454785
30 Jun 232,12350955279
31 Mar 232,16653853675
01 Jan 232,40558757575
30 Sep 222,12343747356
30 Jun 222,17243647443
31 Mar 222,18744047543
01 Jan 221,97239142736
30 Sep 211,73038639428
30 Jun 211,41329932924
31 Mar 211,12421728216
01 Jan 211,05018627211
30 Sep 2093713726011
30 Jun 2094114626511
31 Mar 2094916126312
01 Jan 2091616026415
30 Sep 1986712729223
30 Jun 198359129925
31 Mar 198197630329
01 Jan 198608031029
30 Sep 188056027531
30 Jun 187914425441
31 Mar 187713025134
31 Dec 176852224429
30 Sep 176523426715
30 Jun 17600522650
31 Mar 17530522400
31 Dec 16561502300
30 Sep 16545681900
30 Jun 16527661720
31 Mar 16554811680
31 Dec 15500781590
30 Sep 15568701490
30 Jun 15587751450
31 Mar 15513321360
31 Dec 144891231330
30 Sep 144031051380
30 Jun 143931181370
31 Mar 144441491470
31 Dec 13478701480

Kaliteli Kazançlar: 000403 has high quality earnings.

Büyüyen Kar Marjı: 000403's current net profit margins (29.1%) are higher than last year (24.7%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 000403's earnings have grown significantly by 33.6% per year over the past 5 years.

Büyüme Hızlandırma: 000403's earnings growth over the past year (47%) exceeds its 5-year average (33.6% per year).

Kazançlar vs. Sektör: 000403 earnings growth over the past year (47%) exceeded the Biotechs industry 0.08%.


Özkaynak Getirisi

Yüksek ROE: 000403's Return on Equity (10.6%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin